Use of glycogen phosphorylase inhibitors

摘要

Individuals in whom Type 2 diabetes mellitus has not yet presented, but in whom there is an increased risk of developing such condition, can be treated prophylactically with a glycogen phosphorylase inhibitor; a glycogen phosphorylase inhibitor and a non-glycogen phosphorylase inhibiting anti-diabetic agent; or a glycogen phosphorylase inhibitor and an anti-obesity agent.